Vaccine completion was measured by receipt of the three doses of the Twinrix HAV/HBV vaccine series, recorded at baseline, 1 month, and 6 months (with a 2-month grace period) by the research nurse. At 6 months postbaseline, all participants completed a posttreatment survey identical to the pretreatment survey, with the exception of immutable sociodemographic items.